Login / Signup

Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial.

Thomas Eldridge Stinchcombe
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
  • small cell lung cancer
  • phase iii
  • study protocol
  • epidermal growth factor receptor
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label